APPLICATION
NDA050497
TYPE
NDA
ORIGINAL APPROVAL
1976-11-09
LATEST ACTION
2003-01-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
TICARDiscontinued
TICARCILLIN DISODIUM EQ 20GM BASE/VIAL · INJECTABLE · INJECTION
TICARDiscontinued
TICARCILLIN DISODIUM EQ 3GM BASE/VIAL · INJECTABLE · INJECTION
TICARDiscontinued
TICARCILLIN DISODIUM EQ 30GM BASE/VIAL · INJECTABLE · INJECTION
TICARDiscontinued
TICARCILLIN DISODIUM EQ 6GM BASE/VIAL · INJECTABLE · INJECTION
TICARDiscontinued
TICARCILLIN DISODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2003-01-03Manufacturing (CMC) · Supplement 60 · standardAP
2002-02-08Manufacturing (CMC) · Supplement 58 · standardAP
2001-08-02Manufacturing (CMC) · Supplement 57 · standardAP
2001-08-02Manufacturing (CMC) · Supplement 56 · standardAP
1998-02-05Manufacturing (CMC) · Supplement 55 · standardAP
1997-12-23Manufacturing (CMC) · Supplement 53 · standardAP
1997-08-29Manufacturing (CMC) · Supplement 54 · standardAP
1996-09-04Manufacturing (CMC) · Supplement 52 · standardAP
1996-02-06Manufacturing (CMC) · Supplement 51 · standardAP
1995-11-09Labeling · Supplement 49 · standardAP
1994-11-16Manufacturing (CMC) · Supplement 50 · standardAP
1993-04-13Manufacturing (CMC) · Supplement 43 · standardAP
1993-04-07Manufacturing (CMC) · Supplement 47 · standardAP
1992-12-30Labeling · Supplement 45 · standardAP
1992-12-30Labeling · Supplement 44 · standardAP
1992-12-30Labeling · Supplement 42 · standardAP
1992-12-22Manufacturing (CMC) · Supplement 46 · standardAP
1992-05-28Manufacturing (CMC) · Supplement 41 · standardAP
1992-01-14Labeling · Supplement 37 · standardAP
1992-01-02Manufacturing (CMC) · Supplement 38 · standardAP
1992-01-02Manufacturing (CMC) · Supplement 40 · standardAP
1990-02-26Manufacturing (CMC) · Supplement 39 · standardAP
1989-08-30Manufacturing (CMC) · Supplement 33 · standardAP
1976-11-09Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.